Noticias de MGNX_US

Noticias del mercado

Últimas noticias sobre MGNX_US — 60 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: MGNX_US ✕ 60 resultados
12/03/2026 MGNX_US — GuruFocus
MacroGenics Inc at Barclays Global Healthcare Conference Transcript
10/03/2026 MGNX_US — MarketBeat
Barclays Forecasts Strong Price Appreciation for MacroGenics (NASDAQ:MGNX) Stock
10/03/2026 MGNX_US — Investing.com
Stifel reiterates MacroGenics stock rating with $4 price target
10/03/2026 MGNX_US — GuruFocus ES ← EN
Barclays eleva el precio objetivo de los productos macrogénicos (MGNX) a 4,00 dólares, Ma
10/03/2026 MGNX_US — Investing.com India ES ← EN
Las ganancias de MacroGenics Inc no alcanzaron los 0,03 dólares y los ingresos superaron las estimaciones
10/03/2026 MGNX_US — Minichart
MacroGenics, Inc. 2025 Annual Report: Innovative Antibody-Based Cancer Therapeutics, Pipeline, and Risk Factors Overview
09/03/2026 MGNX_US — GlobeNewswire
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
09/03/2026 MGNX_US — Investing.com
MacroGenics Inc earnings missed by $0.03, revenue topped estimates
09/03/2026 MGNX_US — Stock Titan
Cancer biotech MacroGenics lines up 2026 trial data, funds into 2027
09/03/2026 MGNX_US — IndexBox
MacroGenics Q4 2025 Earnings: Loss Below Estimates, Revenue Beats Forecast - News and Statistics
09/03/2026 MGNX_US — Yahoo Finance
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates
07/03/2026 MGNX_US — Seeking Alpha
Incyte fails to win FDA label expansion for cancer therapy due to issues at Novo plant
27/02/2026 MGNX_US — The Manila Times
MacroGenics to Participate in Upcoming Investor Conferences
26/02/2026 MGNX_US — Yahoo Finance
MacroGenics to Participate in Upcoming Investor Conferences
26/02/2026 MGNX_US — Stock Titan
Cancer drug developer MacroGenics lines up March investor talks
24/02/2026 MGNX_US — Investing.com Nigeria
MacroGenics stock falls after FDA places partial clinical hold By Investing.com
24/02/2026 MGNX_US — Seeking Alpha
MacroGenics drops after FDA partial clinical hold on lead program
24/02/2026 MGNX_US — GuruFocus ES ← EN
MacroGenics (MGNX) enfrenta un revés por parte de la FDA con el control parcial de Lorige
23/02/2026 MGNX_US — GlobeNewswire
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
23/02/2026 MGNX_US — GuruFocus
FDA Imposes Partial Clinical Hold on MacroGenics' (MGNX) Study

Página 3 de 3

keyboard_arrow_up